Bio-Works Technologies operates in biotechnology. The company develops products that separate and purify molecules in the production of pharmaceuticals. The technology is based on chromatography, which is intended to handle the drug substance. Customers are found in the European market where the products are sold via distribution partners and to companies in the pharmaceutical industry, as well as research institutes and universities. The company was founded in 2006 and has its headquarters in Uppsala.

Quotes for Bio-Works Technologies AB

Right Now

+/-
0.245
%
14,80%
Latest
1.9
High
2.05
Low
1.655
Volume
731 442
Turnover (SEK)
1 428 324
Market Value (MSEK)
149,6
Time (Latest trade)
2025-07-16 17:04

Board

CEO

  • Lone Carlbom

Chairperson of the Board

  • Peter Ehrenheim

Board

  • Jonas Ahlén
  • Peter Nählstedt
  • Thomas Gür

Largest Owners

Name Capital % Votes % Date
Staffan Persson 18,61 18,61 2025-06-26
Erik Åfors 15,56 15,56 2025-06-26
Avanza Pension 5,57 5,57 2025-06-26
Peter von Ehrenheim 3,26 3,26 2025-06-26
Dariush Hosseinian 3,18 3,18 2025-06-26
Laurent Leksell med bolag 2,93 2,93 2025-06-26
Futur Pension 2,85 2,85 2025-06-26
Nordnet Pensionsförsäkring 2,13 2,13 2025-06-26
Olof Mathias Malmgren 1,72 1,72 2025-06-26
Karl Edvin Severin Molander 1,25 1,25 2025-06-26
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2025-08-22 Delårsrapport 2025-Q2

  • 2026-02-20 Bokslutskommuniké 2025